Literature DB >> 2991967

Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat.

F J Vaccarino, F E Bloom, G F Koob.   

Abstract

A quaternary derivative of naloxone, methyl naloxonium chloride (MN), was administered intracerebrally to rats trained to self-administer heroin intravenously. Increases in intravenous (IV) heroin self-administration rates were found following injections of low doses of MN into the nucleus accumbens (N.Acc), but not following injections of low doses of MN into the ventral tegmental area (VTA). These results were interpreted to suggest that the rewarding properties of IV heroin were decreased following N.Acc opiate receptor blockade. The relative insensitivity of the VTA to MN treatment was taken to suggest that VTA opiate receptors are either not essential or play a secondary role in mediating IV heroin self-administration. The present data support the notion that post-synaptic N.Acc opiate receptors play a crucial role in maintaining IV heroin self-administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991967     DOI: 10.1007/bf00431681

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine.

Authors:  D C Roberts; M E Corcoran; H C Fibiger
Journal:  Pharmacol Biochem Behav       Date:  1977-06       Impact factor: 3.533

2.  The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey.

Authors:  M C Wilson; C R Schuster
Journal:  Psychopharmacologia       Date:  1972

Review 3.  Behavioural effects of opioid peptides.

Authors:  G F Koob; F E Bloom
Journal:  Br Med Bull       Date:  1983-01       Impact factor: 4.291

4.  Nalorphine-induced changes in morphine self-administration in rhesus monkeys.

Authors:  S R Goldberg; J H Woods; C R Schuster
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

5.  Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward.

Authors:  R A Yokel; R A Wise
Journal:  Science       Date:  1975-02-14       Impact factor: 47.728

6.  Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat.

Authors:  F J Vaccarino; H O Pettit; F E Bloom; G F Koob
Journal:  Pharmacol Biochem Behav       Date:  1985-09       Impact factor: 3.533

7.  (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.

Authors:  C B Pert; A Pert; J K Chang; B T Fong
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

8.  Reinforcing effects of morphine in the nucleus accumbens.

Authors:  M E Olds
Journal:  Brain Res       Date:  1982-04-15       Impact factor: 3.252

9.  Self-stimulation and circling reveal functional differences between medial and lateral substantia nigra.

Authors:  F Vaccarino; K B Franklin
Journal:  Behav Brain Res       Date:  1982-07       Impact factor: 3.332

10.  Changes in morphine self-administration in rats induced by prostaglandin E1 and naloxone.

Authors:  J R Weeks; R J Collins
Journal:  Prostaglandins       Date:  1976-07
View more
  31 in total

1.  Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence.

Authors:  S H Criner; J Liu; G Schulteis
Journal:  Neuroscience       Date:  2006-12-11       Impact factor: 3.590

Review 2.  The neurocircuitry of addiction: an overview.

Authors:  M W Feltenstein; R E See
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

3.  Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin.

Authors:  A L Svingos; A Moriwaki; J B Wang; G R Uhl; V M Pickel
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

4.  An analysis of the paradoxical effect of morphine on runway speed and food consumption.

Authors:  W A Corrigall; M A Linseman; R M D'Onofrio; H Lei
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse.

Authors:  C L Walters; J A Blendy
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

6.  5-HT3 antagonists reduce morphine self-administration in rats.

Authors:  S C Hui; E L Sevilla; C W Ogle
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Acute and chronic ethanol modulate dopamine D2-subtype receptor responses in ventral tegmental area GABA neurons.

Authors:  Kimberly H Ludlow; Katie D Bradley; David W Allison; Seth R Taylor; Jordan T Yorgason; David M Hansen; Christine H Walton; Sterling N Sudweeks; Scott C Steffensen
Journal:  Alcohol Clin Exp Res       Date:  2009-03-06       Impact factor: 3.455

8.  Contingent and non-contingent effects of low-dose ethanol on GABA neuron activity in the ventral tegmental area.

Authors:  Scott C Steffensen; Christine H Walton; David M Hansen; Jordan T Yorgason; Roger A Gallegos; Jose R Criado
Journal:  Pharmacol Biochem Behav       Date:  2008-10-29       Impact factor: 3.533

9.  ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers.

Authors:  Stephanie E Sillivan; John D Whittard; Michelle M Jacobs; Yanhua Ren; Amin R Mazloom; Francesca F Caputi; Monika Horvath; Eva Keller; Avi Ma'ayan; Ying-Xian Pan; Lillian W Chiang; Yasmin L Hurd
Journal:  Biol Psychiatry       Date:  2013-05-20       Impact factor: 13.382

10.  Opioid system in the medial prefrontal cortex mediates binge-like eating.

Authors:  Angelo Blasio; Luca Steardo; Valentina Sabino; Pietro Cottone
Journal:  Addict Biol       Date:  2013-01-24       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.